Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis

Ann Surg Oncol. 2023 Sep;30(9):5457-5458. doi: 10.1245/s10434-023-13834-4. Epub 2023 Jul 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cytoreduction Surgical Procedures
  • Female
  • Humans
  • Liver Neoplasms* / secondary
  • Liver Neoplasms* / surgery
  • Neoplasm, Residual / pathology
  • Neuroendocrine Tumors* / pathology
  • Neuroendocrine Tumors* / surgery
  • Ovarian Neoplasms* / pathology
  • Retrospective Studies